Invitrogen™ Peptide synthétique APRIL humain
Synthetic Peptide
- Gene ID (Entrez)
- 8741
- Espèces
- Human
- Méthode de purification
- purified
- Numéro d’adhésion
- O75888
- Nom usuel
- Human APRIL
- Marque
- Invitrogen
"/>
Synthetic Peptide
APRIL Synthetic Peptide, PEP-0067, from Invitrogen.
Members in the TNF superfamily regulate immune responses and induce apoptosis. A novel member in the TNF family was recently identified by several groups and designated APRIL (for A PRoliferation-Inducing Ligand), TALL2 (for TNF and ApoL-related Leukocyte-expressed Ligand 2), and TRDL 1a (for TNF related death ligand 1a) in human and mouse. Two receptors for APRIL were recently identified and designated TACI and BCMA. APRIL stimulates B and T cell proliferation, triggers humoral immune responses, activates NF-kB, and induces cell death. APRIL and its close relative of BlyS and their receptors BCMA and TACI are involved in diseases of autoimmunity and cancer.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-176322 |
| Réf. fabricant | 15206299 |
| Gene ID (Entrez) | 8741 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | O75888 |
| Nom usuel | Human APRIL |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | TNFSF13 |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |